1Bell, LP, Hectorn, KJ, Reynolds, H, et al. (1990) Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia. Am J Clin Nutr 52, 1020–1026.
2Lipsky, H, Gloger, M & Frishman, WH (1990) Dietary fiber for reducing blood cholesterol. J Clin Pharmacol 30, 699–703.
3Roberts, DC, Truswell, AS, Bencke, A, et al. (1994) The cholesterol-lowering effect of a breakfast cereal containing psyllium fibre. Med J Aust 161, 660–664.
4Anderson, JW, Riddell-Mason, S, Gustafson, NJ, et al. (1992) Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Am J Clin Nutr 56, 93–98.
5Fernandez, ML, Vergara-Jimenez, M, Romero, AL, et al. (1995) Gender differences in response to dietary soluble fiber in guinea pigs: effects of pectin, guar gum, and psyllium. J Lipid Res 36, 2191–2202.
6Romero, AL, Romero, JE, Galaviz, S, et al. (1998) Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern Mexico. J Am Coll Nutr 17, 601–608.
7Anderson, JW, Allgood, LD, Lawrence, A, et al. (2000) Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 71, 472–479.
8Wei, ZH, Wang, H, Chen, XY, et al. (2009) Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials. Eur J Clin Nutr 63, 821–827.
9Turley, SD, Daggy, BP & Dietschy, JM (1994) Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver. Gastroenterology 107, 444–452.
10Turley, SD, Daggy, BP & Dietschy, JM (1996) Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in hamsters with dietary-induced hypercholesterolemia. J Cardiovasc Pharmacol 27, 71–79.
11Buhman, KK, Furumoto, EJ, Donkin, SS, et al. (1998) Dietary psyllium increases fecal bile acid excretion, total steroid excretion and bile acid biosynthesis in rats. J Nutr 128, 1199–1203.
12Trautwein, EA, Kunath-Rau, A & Erbersdobler, HF (1999) Increased fecal bile acid excretion and changes in the circulating bile acid pool are involved in the hypocholesterolemic and gallstone-preventive actions of psyllium in hamsters. J Nutr 129, 896–902.
13Daggy, BP, O'Connell, NC, Jerdack, GR, et al. (1997) Additive hypocholesterolemic effect of psyllium and cholestyramine in the hamster: influence on fecal sterol and bile acid profiles. J Lipid Res 38, 491–502.
14Chiang, JY (1998) Regulation of bile acid synthesis. Front Biosci 3, d176–d193.
15Maruyama, T, Miyamoto, Y, Nakamura, T, et al. (2002) Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 298, 714–719.
16Vassileva, G, Golovko, A, Markowitz, L, et al. (2006) Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J 398, 423–430.
17Houten, SM, Watanabe, M & Auwerx, J (2006) Endocrine functions of bile acids. EMBO J 25, 1419–1425.
18Keitel, V, Kubitz, R & Haussinger, D (2008) Endocrine and paracrine role of bile acids. World J Gastroenterol 14, 5620–5629.
19Chiang, JY (2009) Bile acids: regulation of synthesis. J Lipid Res 50, 1955–1966.
20Wang, ZQ, Zuberi, AR, Zhang, XH, et al. (2007) Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet. Metabolism 56, 1635–1642.
21Chan, MY & Heng, CK (2008) Sequential effects of a high-fiber diet with psyllium husks on the expression levels of hepatic genes and plasma lipids. Nutrition 24, 57–66.
22Matsumoto, K & Yokoyama, S (2010) Gene expression analysis on the liver of cholestyramine-treated type 2 diabetic model mice. Biomed Pharmacother 64, 373–378.
23Ando, H, Takamura, T, Matsuzawa-Nagata, N, et al. (2009) The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis. Biochem Biophys Res Commun 380, 684–688.
24Oike, H, Nagai, K, Fukushima, T, et al. (2010) High-salt diet advances molecular circadian rhythms in mouse peripheral tissues. Biochem Biophys Res Commun 402, 7–13.
25Jeanty, C, Longrois, D, Mertes, PM, et al. (2010) An optimized protocol for microarray validation by quantitative PCR using amplified amino allyl labeled RNA. BMC Genomics 11, 542.
26Buhman, KK, Furumoto, EJ, Donkin, SS, et al. (2000) Dietary psyllium increases expression of ileal apical sodium-dependent bile acid transporter mRNA coordinately with dose-responsive changes in bile acid metabolism in rats. J Nutr 130, 2137–2142.
27Galisteo, M, Moron, R, Rivera, L, et al. (2010) Plantago ovata husks-supplemented diet ameliorates metabolic alterations in obese Zucker rats through activation of AMP-activated protein kinase. Comparative study with other dietary fibers. Clin Nutr 29, 261–267.
28de Wilde, J, Smit, E, Mohren, R, et al. (2009) An 8-week high-fat diet induces obesity and insulin resistance with small changes in the muscle transcriptome of C57BL/6J mice. J Nutrigenet Nutrigenomics 2, 280–291.
29Hannan, JM, Ali, L, Khaleque, J, et al. (2006) Aqueous extracts of husks of Plantago ovata reduce hyperglycaemia in type 1 and type 2 diabetes by inhibition of intestinal glucose absorption. Br J Nutr 96, 131–137.
30North, CJ, Venter, CS & Jerling, JC (2009) The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 63, 921–933.
31Watanabe, M, Houten, SM, Mataki, C, et al. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484–489.
32Staiger, H, Haas, C, Machann, J, et al. (2009) Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 58, 579–589.
33Campos, FG, Logullo Waitzberg, AG, Kiss, DR, et al. (2005) Diet and colorectal cancer: current evidence for etiology and prevention. Nutr Hosp 20, 18–25.
34Gao, Z, Yin, J, Zhang, J, et al. (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509–1517.
35Yamauchi, M, Kambe, F, Cao, X, et al. (2008) Thyroid hormone activates adenosine 5′-monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-beta. Mol Endocrinol 22, 893–903.
36Hurley, RL, Anderson, KA, Franzone, JM, et al. (2005) The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280, 29060–29066.
37Garcia-Martinez, JM & Alessi, DR (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416, 375–385.
38Brunet, A, Park, J, Tran, H, et al. (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21, 952–965.
39Lang, F, Gorlach, A & Vallon, V (2009) Targeting SGK1 in diabetes. Expert Opin Ther Targets 13, 1303–1311.
40Schiaffino, S & Mammucari, C (2011) Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 1, 4.